Related news from
Thu, 09 Jul 2026 18:21:00 +0000	Should You Retain CAH Stock After Removal From Several Russell Indices? CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.
Thu, 09 Jul 2026 13:24:35 +0000	McKesson Stock Is Shrinking, and That's The Point for Owners While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.
Thu, 09 Jul 2026 08:05:00 +0000	3 Market-Beating Stocks for Long-Term Investors Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
Wed, 08 Jul 2026 18:24:21 +0000	McKesson Stock Is Shrinking, And That's The Point While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.
Mon, 06 Jul 2026 17:29:01 +0000	Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Sat, 04 Jul 2026 14:20:48 +0000	Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done” Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]
Wed, 01 Jul 2026 20:30:00 +0000	Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release CONSHOHOCKEN, Pa., July 01, 2026--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026.
Tue, 30 Jun 2026 13:41:46 +0000	Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase Cencora (COR) was Smart Insider's stock pick of the week after Chair Mark Durcan bought $1 million i
Mon, 29 Jun 2026 19:30:29 +0000	Is McKesson Corporation (MCK) A Good Stock To Buy Now? Is MCK a good stock to buy? We came across a bullish thesis on McKesson Corporation on r/ValueInvesting by OnTheStreetwithLou. In this article, we will summarize the bulls’ thesis on MCK. McKesson Corporation’s share was trading at $763.91 as of June 23rd. MCK’s trailing and forward P/E were 19.41 and 16.81 respectively according to Yahoo Finance. McKesson […]
Mon, 29 Jun 2026 11:07:50 +0000	Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap If you are wondering whether Cencora stock is priced for opportunity or already reflects its strengths, the current setup invites a closer look at what investors are really paying for. Cencora shares last closed at US$286.13, with the stock up 5.5% over the past week and 6.2% over the past month, while still showing a 15.6% decline year to date and a 3.9% decline over the past year. These shorter term moves sit alongside a longer 3 year return of 53.8% and a 5 year return of 158.3%. This...
Sun, 28 Jun 2026 18:05:52 +0000	Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO Cencora (NYSE:COR) has launched a multi-site pilot of its upgraded Nucleus inventory management solution for specialty physician practices. The pilot focuses on improving medication workflow efficiency and inventory visibility across participating sites. The company has appointed Samantha Hammock, formerly of Verizon, as Chief Human Resources Officer, succeeding Silvana Battaglia. These developments reflect operational and leadership changes that may affect Cencora's specialty care...
Fri, 26 Jun 2026 19:04:25 +0000	3 Big Reasons to Love Cencora (COR) Over the past six months, Cencora’s stock price fell to $287.06. Shareholders have lost 15.8% of their capital, which is disappointing considering the S&P 500 has climbed by 6.2%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Fri, 26 Jun 2026 09:20:25 +0000	2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Thu, 25 Jun 2026 21:15:01 +0000	AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.
Tue, 23 Jun 2026 23:53:07 +0000	Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.
Fri, 19 Jun 2026 17:10:34 +0000	Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet.
Fri, 19 Jun 2026 12:36:00 +0000	CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
Thu, 18 Jun 2026 16:49:00 +0000	COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.
Thu, 18 Jun 2026 14:33:00 +0000	Cencora Launches Enhanced Nucleus Solution for Specialty Practices COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.
Thu, 18 Jun 2026 12:00:00 +0000	Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!